Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS

In the 12-month phase 3 TRANSFORMS study, fingolimod showed greater efficacy than intramuscular interferon beta (IFNβ)-1a in patients with relapsing–remitting multiple sclerosis (RRMS). This study analyzed fingolimod efficacy compared with IFNβ-1a in patient subgroups from TRANSFORMS. Patients were...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Cohen, Jeffrey A., Barkhof, Frederik, Comi, Giancarlo, Izquierdo, Guillermo, Khatri, Bhupendra, Montalban, Xavier, Pelletier, Jean, Eckert, Benjamin, Häring, Dieter A., Francis, Gordon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3737385/
https://ncbi.nlm.nih.gov/pubmed/23632946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-013-6932-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia